{
  "ptid_time": "036_S_4538_2020-09-14",
  "img_path": "/data/qiuhui/data/adni/images/036_S_4538/2020-09-14/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 63,175 mm³, 70.9% above the reference mean. With a Z-score of 1.91 (97.2th percentile), this represents moderate enlargement; hippocampal volume measures 4,283 mm³, 34.1% below the reference mean. With a Z-score of -2.73 (0.3th percentile), this represents significant atrophy; whole brain volume measures 836,761 mm³, 9.8% below the reference mean. With a Z-score of -1.18 (11.9th percentile), this represents mild atrophy; entorhinal cortex volume measures 1,823 mm³, 47.4% below the reference mean. With a Z-score of -2.56 (0.5th percentile), this represents significant atrophy; fusiform gyrus volume measures 14,788 mm³, 8.2% below the reference mean. With a Z-score of -0.62 (26.9th percentile), this represents normal volume ; middle temporal gyrus volume measures 15,997 mm³, 11.3% below the reference mean. With a Z-score of -1.00 (15.8th percentile), this represents mild atrophy. ",
  "text_data": "Age is 87.3 years. Gender is Female. Education: 15 years. MMSE: 20.0. MoCA: 13.0. Logical Memory: 0.0. APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.35 SUVR (significant elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the hippocampus and entorhinal cortex, both key regions affected in Alzheimer's disease, along with moderate ventricular enlargement and mild whole-brain atrophy. The cognitive scores (MMSE 20, MoCA 13) indicate substantial impairment, and the presence of an APOE4 allele and elevated AV45 (amyloid PET) further support Alzheimer's pathology.  \n\n**Diagnosis:** **Dementia** (likely Alzheimer’s disease)  \n**Confidence:** **High**",
  "timestamp": "2025-07-26T06:15:36.774375"
}